SuperworthCogent Biosciences shares outstanding COGT
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 171M
- On a year earlier
- +49.4%
- more shares
Cogent Biosciences had 171M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 49.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 149.8M | +35% |
| FY2024 | 111.1M | +28% |
| FY2023 | 86.7M | +23% |
| FY2022 | 70.5M | +69% |
| FY2021 | 41.7M | +118% |
| FY2020 | 19.1M | +149% |
| FY2019 | 7.7M | +2% |
| FY2018 | 7.5M | +194% |
| FY2017 | 2.5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 171M | +49% | |
| Q1 FY26 | 162.2M | +43% | |
| Q4 FY25 | 149.8M | +35% | |
| Q3 FY25 | 137.6M | +25% | |
| Q2 FY25 | 114.5M | +15% | |
| Q1 FY25 | 113.3M | +20% | |
| Q4 FY24 | 111.1M | +28% | |
| Q3 FY24 | 110.2M | +28% | |
| Q2 FY24 | 99.2M | +33% | |
| Q1 FY24 | 94.8M | +34% | |
| Q4 FY23 | 86.7M | +23% | |
| Q3 FY23 | 86.2M | +24% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Cogent Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.